Quick Answer
vTv Therapeutics Inc. reported Cash And Cash Equivalents At Carrying Value of $88.93 million for the year ending 2025.
- vTv Therapeutics Inc. showed an increase of +142.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from vTv Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), vTv Therapeutics Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 4,087.0%.
- Historical annual values: Fiscal year 2025: $88.93 million | Fiscal year 2024: $36.75 million | Fiscal year 2023: $9.45 million | Fiscal year 2022: $12.13 million | Fiscal year 2021: $13.42 million | Fiscal year 2020: $5.75 million | Fiscal year 2019: $1.78 million | Fiscal year 2018: $1.68 million | Fiscal year 2017: $11.76 million | Fiscal year 2016: $51.51 million | Fiscal year 2015: $88.00 million | Fiscal year 2014: $1.38 million | Fiscal year 2013: $1.09 million | Fiscal year 2012: $2.12 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: